


| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Darifenacin hydrobromide | Initial report | 07.11.2025 | Other | Darifenacin Aristo 15 mg prolonged-release tablets | |
| Tolterodine tartrate | Initial report | 07.11.2025 | Other | Tolterodine Aristo 1 mg film-coated tablets | |
| Tolterodine tartrate | Initial report | 07.11.2025 | Other | Tolterodine-Aristo 2 mg film-coated tablets | |
| Posaconazole | Change notification | 07.11.2025 | Other | Posaconazole HEXAL 40 mg/ml oral suspension | |
| Tolterodine tartrate | Initial report | 07.11.2025 | Other | Detrusitol 1 mg film-coated tablets | |
| Beclomethasone dipropionate (Ph.Eur.) | Change notification | 07.11.2025 | Other | Beclorhinol aquosum 50 micrograms | |
| Paliperidone palmitate | Change notification | 06.11.2025 | Other | XEPLION 25 mg prolonged-release suspension for injection – OP1ml | |
| Rifampicin sodium | Change notification | 06.11.2025 | Other | Eremfat i.v. 600mg | |
| Nitrendipine | Initial report | 06.11.2025 | Other | Nitrendipine AL 10 | |
| Urapidil | Initial report | 06.11.2025 | Other | Urapidil AL 90 mg hard capsules, delayed release | |
| Urapidil | Initial report | 06.11.2025 | Other | Urapidil AL 30 mg hard capsules, delayed release | |
| Imiquimod | Change notification | 06.11.2025 | Production problem | Aldara 5% cream – OP24 | |
| Calcium folinate hydrate | Change notification | 06.11.2025 | Production problem | Calcium folinate onkovis 10 mg/ml solution for injection | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 06.11.2025 | Other | Quetiapine AL 100 mg film-coated tablets | |
| Salbutamol sulfate | Initial report | 05.11.2025 | Other | Bronchospray Autohaler | |
| Imiquimod | Change notification | 05.11.2025 | Production problem | Imikeraderm 50 mg/g cream | |
| Sodium mycophenolate | Initial report | 05.11.2025 | Other | Mycophenolic acid HEXAL 180 mg gastro-resistant tablets | |
| Sodium mycophenolate | Change notification | 05.11.2025 | Other | Mycophenolic acid HEXAL 360 mg gastro-resistant tablets | |
| Sitagliptin hydrochloride monohydrate | Change notification | 05.11.2025 | Production problem | Sitagliptin PUREN 50 mg film-coated tablets | |
| Nimodipine | Change notification | 05.11.2025 | Other | Nimodipine Hexal 30 mg | |
| Propranolol hydrochloride | Initial report | 05.11.2025 | Other | Propra-ratiopharm 40 mg film-coated tablets | |
| Propranolol hydrochloride | Initial report | 05.11.2025 | Other | Propra-ratiopharm 10 mg film-coated tablets | |
| Dexamethasone dihydrogen phosphate disodium (Ph.Eur.) | Initial report | 05.11.2025 | Other | Dexa-ratiopharm 4 mg solution for injection | |
| Ipratropium bromide (Ph.Eur.) | Change notification | 05.11.2025 | Production problem | Ipratropium Teva 250 micrograms/1 ml solution for nebulizer | |
| Buprenorphine | Change notification | 05.11.2025 | Other | Buprenorphine AWD Matrix 52.5 micrograms/h Transdermal patch | |
| Buprenorphine | Change notification | 05.11.2025 | Other | Buprenorphine AWD Matrix 70 micrograms/h Transdermal patch | |
| Methylphenidate hydrochloride | Change notification | 05.11.2025 | Other | Methylphenidate-ratiopharm 10 mg modified-release hard capsules | |
| Galantamine hydrobromide | Change notification | 05.11.2025 | Other | Galantamine-ratiopharm 8 mg hard capsules, delayed release | |
| Carbamazepine | Change notification | 05.11.2025 | Other | Carbamazepine-ratiopharm 200 mg prolonged-release tablets | |
| Buprenorphine | Change notification | 05.11.2025 | Other | Buprenorphine-ratiopharm 70 micrograms/h transdermal patch | |
| Buprenorphine | Change notification | 05.11.2025 | Other | Buprenorphine-ratiopharm 52.5 micrograms/h Transdermal patch | |
| Buprenorphine | Change notification | 05.11.2025 | Other | Buprenorphine-ratiopharm 35 micrograms/h transdermal patch | |
| Alprazolam | Change notification | 05.11.2025 | Other | Alprazolam-ratiopharm 1.0 mg tablets | |
| Methylphenidate hydrochloride | Change notification | 05.11.2025 | Other | Methylphenidate-ratiopharm 40 mg modified-release hard capsules | |
| Doxepine hydrochloride (Ph.Eur.) | Change notification | 04.11.2025 | Production problem | Doxepin 25 Holsten | |
| Doxepine hydrochloride (Ph.Eur.) | Change notification | 04.11.2025 | Other | Doxepin 50 Holsten | |
| Doxepine hydrochloride (Ph.Eur.) | Change notification | 04.11.2025 | Production problem | Doxepin 75 Holsten | |
| Gabapentin | Change notification | 04.11.2025 | Other | Gabapentin Holsten 300 mg hard capsules | |
| Gabapentin | Change notification | 04.11.2025 | Production problem | Gabapentin Holsten 600 mg film-coated tablets | |
| Gabapentin | Change notification | 04.11.2025 | Other | Gabapentin Holsten 800 mg film-coated tablets | |
| Mercaptopurine | Change notification | 04.11.2025 | Other | Mercaptopurine Holsten 50 mg tablets | |
| Levetiracetam | Change notification | 04.11.2025 | Other | Levetiracetam Holsten 250 mg film-coated tablets | |
| Ipratropium bromide (Ph.Eur.); salbutamol sulfate | Change notification | 04.11.2025 | Production problem | COMBIPRASAL 0.5 mg / 2.5 mg solution for nebulizer | |
| Ipratropium bromide | Change notification | 04.11.2025 | Production problem | Ipratropium bromide 250 micrograms / 1 ml Stulln | |
| Levetiracetam | Initial report | 04.11.2025 | Other | Levetiracetam Holsten 750 mg film-coated tablets | |
| Amlodipine besylate; hydrochlorothiazide; valsartan | Initial report | 04.11.2025 | Other | Amlodipine/Valsartan/HCT Holsten 5 mg/160 mg/12.5 mg film-coated tablets | |
| Docetaxel | Initial report | 04.11.2025 | Production problem | Docetaxel Aurobindo 20 mg/ml concentrate for solution for infusion | |
| Venlafaxine hydrochloride | Initial report | 04.11.2025 | Other | Venlafaxine Aurobindo 75 mg hard capsule, delayed release | |
| Topiramate | Initial report | 04.11.2025 | Other | Topiramate PUREN 50 mg film-coated tablets | |
| Tranexamic acid | Initial report | 04.11.2025 | Production problem | Tranexamic acid PUREN 100 mg/ml solution for injection | |
| Duloxetine hydrochloride | Initial report | 04.11.2025 | Other | Duloxetine PUREN 60 mg gastro-resistant hard capsules | |
| Anastrozole | Initial report | 04.11.2025 | Production problem | AnastroPUREN 1 mg film-coated tablets | |
| Duloxetine hydrochloride | Initial report | 04.11.2025 | Other | Duloxetine PUREN 30 mg gastro-resistant hard capsules | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 04.11.2025 | Other | Seroquel Prolong 200 mg prolonged-release tablets | |
| Insulin lispro | Initial report | 04.11.2025 | Other | Humalog KwikPen 100 E/ml solution for injection – OP (5x3ml) | |
| Olanzapine | Change notification | 04.11.2025 | Production problem | ZYPREXA | |
| Ipratropium bromide (Ph.Eur.); salbutamol sulfate | Initial report | 04.11.2025 | Other | Ipratropium/salbutamol Cipla 0.5 mg/2.5 mg solution for nebulizer | |
| Cefazolin sodium | Initial report | 04.11.2025 | Production problem | Cefazolin Hikma 2 g powder for solution for injection/infusion | |
| Amiodarone hydrochloride | Initial report | 04.11.2025 | Other | Amiodarone PUREN 200 mg tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Initial report | 04.11.2025 | Other | Atorvastatin PUREN 80 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 04.11.2025 | Other | Atorvastatin PUREN 20 mg film-coated tablets | |
| Methylphenidate hydrochloride | Change notification | 04.11.2025 | Other | Methylphenidate hydrochloride HEXAL 36 mg prolonged-release tablets | |
| Atomoxetine hydrochloride | Change notification | 04.11.2025 | Other | Atomoxe – 1 A Pharma 100 mg hard capsules | |
| Topiramate | Change notification | 04.11.2025 | Production problem | Topiramate PUREN 100 mg film-coated tablets | |
| Atomoxetine hydrochloride | Change notification | 04.11.2025 | Other | Atomoxe – 1 A Pharma 18 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 04.11.2025 | Other | Atomoxe – 1 A Pharma 25 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 04.11.2025 | Other | Atomoxe – 1 A Pharma 40 mg hard capsules | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 04.11.2025 | Other | Seroquel Prolong 400 mg prolonged-release tablets | |
| Atomoxetine hydrochloride | Change notification | 04.11.2025 | Other | Atomoxe – 1 A Pharma 60 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 04.11.2025 | Other | Atomoxe – 1 A Pharma 80 mg hard capsules | |
| Urapidil | Change notification | 04.11.2025 | Production problem | Urapidil Bluefish 30 mg hard capsules, delayed release | |
| Urapidil | Change notification | 04.11.2025 | Production problem | Urapidil Bluefish 90 mg hard capsules, delayed release | |
| Quetiapine fumarate (Ph.Eur.) | Initial report | 04.11.2025 | Other | Seroquel Prolong 150 mg prolonged-release tablets | |
| Aprepitant | Initial report | 03.11.2025 | Production problem | Aprepitant Zentiva 80 mg hard capsules | |
| Aprepitant | Initial report | 03.11.2025 | Production problem | Aprepitant Zentiva 125 mg hard capsules | |
| Aprepitant | Change notification | 03.11.2025 | Production problem | Aprepitant Zentiva 80 mg and 125 mg hard capsules | |
| Dimenhydrinate | Initial report | 03.11.2025 | Production problem | Dimenhydrinate PANPHARMA 6.2 mg/ml solution for injection (i.v.) | |
| Zonisamide | Initial report | 03.11.2025 | Production problem | Zonisamide Glenmark 100 mg hard capsules | |
| Anastrozole | Change notification | 03.11.2025 | Other | Anastrozole Denk 1 mg film-coated tablets | |
| Perindopril tert-butylamine | Initial report | 03.11.2025 | Other | Perindopril Erbumine Glenmark 4 mg tablets | |
| Riluzole | Initial report | 03.11.2025 | Other | Glentek 50 mg film-coated tablets | |
| Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) | Change notification | 03.11.2025 | Other | Ferrlecit 62.5 mg | |
| Clonidine hydrochloride | Change notification | 03.11.2025 | Other | Clonidine-ratiopharm 75 | |
| Rizatriptan benzoate | Change notification | 03.11.2025 | Production problem | Rizatriptan Glenmark 5 mg tablets | |
| Clonidine hydrochloride | Change notification | 03.11.2025 | Other | Clonidine-ratiopharm 150 | |
| Rizatriptan benzoate | Change notification | 03.11.2025 | Production problem | Rizatriptan Glenmark 5 mg orodispersible tablets | |
| Clonidine hydrochloride | Change notification | 03.11.2025 | Other | Clonidine-ratiopharm 300 | |
| Rizatriptan benzoate | Change notification | 03.11.2025 | Production problem | Rizatriptan Glenmark 10 mg orodispersible tablets | |
| Rizatriptan benzoate | Change notification | 03.11.2025 | Production problem | Rizatriptan Glenmark 10 mg tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 03.11.2025 | Production problem | Quetiapine Glenmark 200 mg prolonged-release tablets | |
| Fusidic acid (Ph.Eur.) | Change notification | 03.11.2025 | Production problem | Fucithalmic 10 mg/g eye drops | |
| Dexketoprofen trometamol | Change notification | 03.11.2025 | Production problem | Sympal inject 50 mg solution for injection/infusion | |
| Hydrocortisone acetate (Ph.Eur.) | Change notification | 03.11.2025 | Production problem | Hydrocortisone-POS N 2.5% | |
| Dexamethasone dihydrogen phosphate disodium (Ph.Eur.); gentamicin sulfate | Change notification | 03.11.2025 | Production problem | Dexa-Gentamicin | |
| Prednisolone acetate | Change notification | 03.11.2025 | Production problem | Predni-POS 1% | |
| Aciclovir | Change notification | 03.11.2025 | Production problem | Virupos | |
| Fluorometholone | Change notification | 03.11.2025 | Production problem | Fluoropos | |
| Gentamicin sulfate | Change notification | 03.11.2025 | Production problem | Gentamicin-POS | |
| Phenylephrine hydrochloride | Change notification | 03.11.2025 | Production problem | Neosynephrine-POS 5% |
| Active ingredients | Status | Update | Specialty |
| diltiazem (hydrochloride) | Supply tension | 07/11/2025 | Tildiem 25 mg, powder and solution for intravenous injection |
| tolvaptan | Supply tension | 07/11/2025 | Tolvaptan Biogaran 30 mg, tablet + Tolvaptan Biogaran 60 mg, tablet |
| urokinase | Return to availability | 07/11/2025 | Thérasolv 250,000 IU, powder for solution for injection/infusion |
| diltiazem (hydrochloride) | Marketing discontinuation | 07/11/2025 | Tildiem 100 mg, powder for solution for injection (IV) |
| chlorpromazine (hydrochloride) | Stock shortage | 07/11/2025 | Largactil 100 mg, film-coated tablet |
| pertuzumab/trastuzumab | Return to availability | 07/11/2025 | Phesgo 1200 mg/600 mg, solution for injection |
| clomipramine (hydrochloride) | Supply tension | 06/11/2025 | Clomipramine Viatris 25 mg, film-coated tablet |
| ornidazole | Return to availability | 05/11/2025 | Tiberal 500 mg, solution for infusion |
| cyamemazine | Stock shortage | 03/11/2025 | Tercian 50 mg/5 mL, injectable solution in ampoule |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| betiatide | Injection, powder for | 1 mg | Current | Emergency Supply Only | Manufacturing | 7/11/2025 |
| tobramycin | Injection, solution | 80 mg | Anticipated | Available | Manufacturing | 7/11/2025 |
| primidone | Tablet, uncoated | 250 mg | Current | Emergency Supply Only | Manufacturing | 7/11/2025 |
| trandolapril | Capsule | 2 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/11/2025 |
| topiramate | Tablet, film coated | 25 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| sodium lactate~magnesium chloride hexahydrate~glucose~sodium chloride~calcium chloride dihydrate | Solution, irrigation | 4.48 g/L~50.8 mg/L~15 g/L~5.38 g/L~183 mg/L | Resolved | Available | Manufacturing | 7/11/2025 |
| glucose~sodium chloride~sodium lactate~magnesium chloride hexahydrate~calcium chloride dihydrate | Solution, irrigation | 25 g/L~5.38 g/L~4.48 g/L~50.8 mg/L~183 mg/L | Resolved | Available | Manufacturing | 7/11/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 4.986 mg | Anticipated | Available | Manufacturing | 7/11/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| sumatriptan succinate | Tablet, film coated | 69.99 mg | Current | Limited Availability | Manufacturing | 7/11/2025 |
| phenobarbital | Tablet, uncoated | 30 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 27 mg~200 mg~100 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/11/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 150 mg~40.5 mg~200 mg | Current | Unavailable | Unexpected increase in consumer demand | 7/11/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 200 mg~54.1 mg~200 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/11/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/11/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 7/11/2025 |
| mebeverine hydrochloride | Tablet, film coated | 135 mg | Current | Limited Availability | Manufacturing | 7/11/2025 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Anticipated | Available | Manufacturing | 7/11/2025 |
| metaraminol tartrate | Injection, solution | 19 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/11/2025 |
| aprepitant | Capsule | 165 mg | Anticipated | Available | Manufacturing | 7/11/2025 |
| fingolimod hydrochloride | Capsule | 560 microgram | Anticipated | Available | Manufacturing | 7/11/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| valsartan~sacubitril | Tablet, film coated | 51.4 mg~48.6 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| sacubitril~valsartan | Tablet, film coated | 24.3 mg~25.7 mg | Current | Unavailable | Manufacturing | 7/11/2025 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, modified release | 56.685 mg~1000 mg | Current | Limited Availability | Manufacturing | 7/11/2025 |
| nitrofurantoin | Capsule, hard | 50 mg | Anticipated | Available | Manufacturing | 7/11/2025 |
| naltrexone hydrochloride | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 7/11/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 7/11/2025 |
| carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Resolved | Available | Manufacturing | 7/11/2025 |
| bumetanide | Tablet, uncoated | 1 mg | Current | Limited Availability | Manufacturing | 7/11/2025 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Current | Limited Availability | Manufacturing | 7/11/2025 |
| magnesium chloride hexahydrate~calcium chloride dihydrate~sodium lactate~sodium chloride~icodextrin | Solution, dialysis | 51 mg/L~257 mg/L~4.5 g/L~5.4 g/L~75 g/L | Resolved | Available | Manufacturing | 7/11/2025 |
| nizatidine | Capsule, hard | 300 mg | Anticipated | Available | Manufacturing | 7/11/2025 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 20.51 mg~16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 7/11/2025 |
| lamotrigine | Tablet, dispersible | 200 mg | Current | Limited Availability | Manufacturing | 7/11/2025 |
| sodium amidotrizoate~amidotrizoate meglumine | Oral Liquid, solution | 100 mg/mL~660 mg/mL | Discontinued | Unavailable | Seasonal depletion of stock | 6/11/2025 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 6/11/2025 |
| minoxidil | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 6/11/2025 |
| ropivacaine hydrochloride | Injection, solution | 75 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 6/11/2025 |
| Infliximab | Injection, powder for | 100 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/11/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 6/11/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 6/11/2025 |
| verapamil hydrochloride | Tablet, modified release | 240 mg | Current | Limited Availability | Manufacturing | 5/11/2025 |
| terbutaline sulfate | Injection, solution | .5 mg/mL | Anticipated | Available | Manufacturing | 5/11/2025 |
| midazolam | Injection, solution | 5 mg/mL | Resolved | Available | Manufacturing | 5/11/2025 |
| pantoprazole sodium sesquihydrate | Tablet, enteric coated | 45.4 mg | Resolved | Available | Unexpected increase in consumer demand | 5/11/2025 |
| Alteplase | Injection, powder for | 50 mg | Current | Limited Availability | Unexpected increase in consumer demand | 5/11/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Resolved | Available | Manufacturing | 5/11/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 5/11/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 13.88 mg~10.844 mg | Current | Unavailable | Manufacturing | 5/11/2025 |
| mesalazine | Granules, modified release | 4 g | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 5/11/2025 |
| dabigatran etexilate mesilate | Capsule, hard | 172.95 mg | Current | Unavailable | Manufacturing | 5/11/2025 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Anticipated | Available | Manufacturing | 5/11/2025 |
| midodrine hydrochloride | Tablet | 5 mg | Current | Unavailable | Manufacturing | 5/11/2025 |
| larotrectinib sulfate | Capsule, hard | 30.7 mg | Resolved | Available | Unexpected increase in consumer demand | 5/11/2025 |
| tenofovir disoproxil succinate~emtricitabine | Tablet, film coated | 300.6 mg~200 mg | Current | Unavailable | Manufacturing | 5/11/2025 |
| flecainide acetate | Tablet | 50 mg | Current | Unavailable | Manufacturing | 5/11/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 5/11/2025 |
| rivaroxaban | Tablet, film coated | 15 mg | Anticipated | Available | Manufacturing | 5/11/2025 |
| furosemide | Injection, solution | 20 mg | Resolved | Available | Manufacturing | 5/11/2025 |
| ethinylestradiol~norethisterone | Tablet, uncoated | 36 microgram~500 microgram | Current | Limited Availability | Manufacturing | 5/11/2025 |
| Alteplase | Diluent, not applicable | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 5/11/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 5/11/2025 |
| flunitrazepam | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 5/11/2025 |
| indometacin | Suppository, moulded | 100 mg | Current | Unavailable | Manufacturing | 4/11/2025 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 4/11/2025 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 4/11/2025 |
| alfentanil hydrochloride | Injection, solution | 1.0876 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 4/11/2025 |
| nystatin | Oral Liquid, suspension | 100000 IU/mL | Current | Unavailable | Unexpected increase in consumer demand | 4/11/2025 |
| pregabalin | Capsule, hard | 25 mg | Current | Unavailable | Manufacturing | 4/11/2025 |
| escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Commercial Changes / Commercial viability | 4/11/2025 |
| escitalopram oxalate | Tablet, film coated | 25.47 mg | Current | Limited Availability | Manufacturing | 4/11/2025 |
| lacosamide | Tablet, film coated | 150 mg | Current | Limited Availability | Manufacturing | 4/11/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 4/11/2025 |
| levothyroxine sodium | Tablet, uncoated | .05 mg | Current | Limited Availability | Manufacturing | 4/11/2025 |
| ramipril | Tablet, uncoated | 1.25 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 4/11/2025 |
| ramipril | Tablet, uncoated | 2.5 mg | Current | Limited Availability | Manufacturing | 4/11/2025 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Limited Availability | Manufacturing | 4/11/2025 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Manufacturing | 4/11/2025 |
| sertraline hydrochloride | Tablet, film coated | 55.96 mg | Current | Unavailable | Manufacturing | 3/11/2025 |
| clozapine | Oral Liquid, suspension | 50 mg/mL | Current | Unavailable | Manufacturing | 3/11/2025 |
| risperidone | Tablet | 1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 3/11/2025 |
| lamivudine | Tablet, film coated | 300 mg | Anticipated | Available | Manufacturing | 3/11/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Anticipated | Available | Manufacturing | 3/11/2025 |
| olanzapine | Tablet, orally disintegrating | 10 mg | Resolved | Available | Manufacturing | 3/11/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 3/11/2025 |
| finasteride | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 3/11/2025 |
| risperidone | Tablet, film coated | .5 mg | Resolved | Available | Manufacturing | 3/11/2025 |
| entecavir | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 3/11/2025 |
| primaquine phosphate | Tablet, uncoated | 13.2 mg | Current | Emergency Supply Only | Manufacturing | 3/11/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Anticipated | Available | Manufacturing | 3/11/2025 |
| nicorandil | Tablet, uncoated | 20 mg | Anticipated | Available | Manufacturing | 3/11/2025 |
| tobramycin | Inhalation, conventional | 60 mg/mL | Anticipated | Available | Manufacturing | 3/11/2025 |
| phenytoin sodium | Capsule, hard | 30 mg | Resolved | Available | Manufacturing | 3/11/2025 |
| bendamustine hydrochloride | Injection, powder for | 25 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 3/11/2025 |
| finasteride | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 3/11/2025 |
| Tocilizumab | Injection, solution | 162 mg | Anticipated | Available | Manufacturing | 3/11/2025 |
| bleomycin sulfate | Injection, powder for | 15000 IU | Anticipated | Available | Manufacturing | 3/11/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, uncoated | 1 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 3/11/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, uncoated | .125 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 3/11/2025 |
November 07, 2025
November 03, 2025
November 07, 2025
November 06, 2025
November 05, 2025
November 04, 2025
November 03, 2025

